HuagongsheHuagongshe Chemistry Print Report · For research reference only
[3-(4-Methyl-piperazin-1-yl)-5-trifluoromethyl-phenyl]-carbamic acid tert-butyl ester → 3-(4-Methylpiperazin-1-YL)-5-(trifluoromethyl)aniline
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | [3-(4-Methyl-piperazin-1-yl)-5-trifluoromethyl-phenyl]-carbamic acid tert-butyl ester | HCID 69244832 | — |
| Reactant | (3-Morpholin-4-yl-5-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester | HCID 86606802 | — |
| Product | 3-(4-Methylpiperazin-1-YL)-5-(trifluoromethyl)aniline | HCID 18543044 | — |
Reaction Steps
Utilising the procedure described in Example 90c, but employing [3-(4-methyl-1-piperazinyl)-5-(trifluoromethyl)phenyl]-carbamic acid, 1,1-dimethylethyl ester (Example 94a) in lieu of [3-(4-morpholinyl)-5-(trifluoromethyl)phenyl]-carbamic acid, 1,1-dimethylethyl ester, afforded the title compound as oil. 1H-NMR (400 MHz, DMSO-d6): 2.20 (s, 3H), 2.42 (m, 4H), 3.07 (m, 4H), 3.32 (br s, 2H), 5.34 (s, 1H) and 6.31 (s, 2H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07956053B2 |
| Source dataset | uspto-grants-2011_06 |
| ORD ID | ord-a5d30fc3173a4ff5b01ff919f661a1ef |
| Source note | uspto-grants-2011_06 |